Irradiated Blood Products Supply

The contract seeks the supply of irradiated red blood cells and platelets to prevent transfusion-associated graft-versus-host disease, a critical requirement for immunocompromised patients. The products must be processed and delivered in strict compliance with medical and safety standards to ensure they are free from viable T-lymphocytes that could trigger TA-GVHD. Delivery is targeted to a specified location in Omaha, Nebraska, with a performance timeline aligned to the needs of the Department of Veterans Affairs, which is the overseeing agency through its Network Contract Office 23. The procurement is structured as a subcontract and involves a highly specialized blood product that must meet stringent irradiation parameters and quality control benchmarks. The solicitation was posted on June 22, 2026, with responses due by July 8, 2026, at 10:00 PM Eastern Time, indicating a short but critical window for interested suppliers. The NAICS code 325414 identifies the industry as biological product manufacturing excluding diagnostics, underscoring the technical nature of the required services. While no set-aside provisions or organizational preferences are specified, the contract emphasizes the urgency and precision of blood product preparation and timely distribution. The absence of a designated point of contact and detailed address information suggests that communication and logistical coordination will be managed through the central procurement system, requiring bidders to rely on the official SAM.gov portal for further instructions and updates.